Clinical Trials Browser

Phase 2 × Cognitive Dysfunction × Memantine × Clear all

NCT06727773 2025-09-02

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

Phase 2 Recruiting

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

NCT04033419 2023-04-20

Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer

Phase 2 Completed

55 enrolled 21 charts

Cognitive Dysfunction